APACHE II score validation in emergency abdominal surgery. A post hoc analysis of the InCare trial

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

APACHE II score validation in emergency abdominal surgery. A post hoc analysis of the InCare trial. / Hansted, Anna K; Møller, Morten H; Møller, Ann M; Vester-Andersen, Morten.

In: Acta Anaesthesiologica Scandinavica, Vol. 64, No. 2, 02.2020, p. 180-187.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Hansted, AK, Møller, MH, Møller, AM & Vester-Andersen, M 2020, 'APACHE II score validation in emergency abdominal surgery. A post hoc analysis of the InCare trial', Acta Anaesthesiologica Scandinavica, vol. 64, no. 2, pp. 180-187. https://doi.org/10.1111/aas.13476

APA

Hansted, A. K., Møller, M. H., Møller, A. M., & Vester-Andersen, M. (2020). APACHE II score validation in emergency abdominal surgery. A post hoc analysis of the InCare trial. Acta Anaesthesiologica Scandinavica, 64(2), 180-187. https://doi.org/10.1111/aas.13476

Vancouver

Hansted AK, Møller MH, Møller AM, Vester-Andersen M. APACHE II score validation in emergency abdominal surgery. A post hoc analysis of the InCare trial. Acta Anaesthesiologica Scandinavica. 2020 Feb;64(2):180-187. https://doi.org/10.1111/aas.13476

Author

Hansted, Anna K ; Møller, Morten H ; Møller, Ann M ; Vester-Andersen, Morten. / APACHE II score validation in emergency abdominal surgery. A post hoc analysis of the InCare trial. In: Acta Anaesthesiologica Scandinavica. 2020 ; Vol. 64, No. 2. pp. 180-187.

Bibtex

@article{2929dfe05af040bfbf327565c5a96c56,
title = "APACHE II score validation in emergency abdominal surgery. A post hoc analysis of the InCare trial",
abstract = "BACKGROUND: Patients undergoing emergency abdominal surgery are at high risk of morbidity and mortality. Accurate identification of high-risk patients is important. The Acute Physiology and Chronic Health Evaluation (APACHE) II score needs to be validated in a larger heterogeneous population before implementation. We aimed to assess the predictive value of the APACHE II score in emergency abdominal surgical patients. Furthermore, we compared the APACHE II score with the American Society of Anesthesiologists (ASA) physical status score and the Charlson Comorbidity Index (CCI).METHODS: We included adult patients undergoing emergency abdominal surgery screened for enrolment in the InCare trial from October 2010 to November 2012. The APACHE II score was evaluated with area under the receiver operating characteristics curve (AUROC) statistics. The primary outcome was 30-day mortality. Secondary outcomes included 90-day mortality and admission to the intensive care unit.RESULTS: We included a total of 885 patients. All-cause 30-day mortality was 5.0%, 90-day mortality was 8.9%, and a total of 7.9% of the patients were admitted to the intensive care unit. The AUROC (95% confidence interval) of the APACHE II score was 0.72 (0.65-0.80) for 30-day mortality, 0.70 (0.64-0.76) for 90-day mortality and 0.65 (0.59-0.71) for admission to the intensive care unit. The CCI performed better in prediction of 90-day mortality (P = .04). All other results for the ASA score and CCI were comparable with the APACHE II score.CONCLUSION: The APACHE II score predicted mortality moderately and admission to intensive care unit poorly in emergency abdominal surgical patients.",
author = "Hansted, {Anna K} and M{\o}ller, {Morten H} and M{\o}ller, {Ann M} and Morten Vester-Andersen",
note = "{\textcopyright} 2019 The Acta Anaesthesiologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.",
year = "2020",
month = feb,
doi = "10.1111/aas.13476",
language = "English",
volume = "64",
pages = "180--187",
journal = "Acta Anaesthesiologica Scandinavica",
issn = "0001-5172",
publisher = "Wiley-Blackwell",
number = "2",

}

RIS

TY - JOUR

T1 - APACHE II score validation in emergency abdominal surgery. A post hoc analysis of the InCare trial

AU - Hansted, Anna K

AU - Møller, Morten H

AU - Møller, Ann M

AU - Vester-Andersen, Morten

N1 - © 2019 The Acta Anaesthesiologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

PY - 2020/2

Y1 - 2020/2

N2 - BACKGROUND: Patients undergoing emergency abdominal surgery are at high risk of morbidity and mortality. Accurate identification of high-risk patients is important. The Acute Physiology and Chronic Health Evaluation (APACHE) II score needs to be validated in a larger heterogeneous population before implementation. We aimed to assess the predictive value of the APACHE II score in emergency abdominal surgical patients. Furthermore, we compared the APACHE II score with the American Society of Anesthesiologists (ASA) physical status score and the Charlson Comorbidity Index (CCI).METHODS: We included adult patients undergoing emergency abdominal surgery screened for enrolment in the InCare trial from October 2010 to November 2012. The APACHE II score was evaluated with area under the receiver operating characteristics curve (AUROC) statistics. The primary outcome was 30-day mortality. Secondary outcomes included 90-day mortality and admission to the intensive care unit.RESULTS: We included a total of 885 patients. All-cause 30-day mortality was 5.0%, 90-day mortality was 8.9%, and a total of 7.9% of the patients were admitted to the intensive care unit. The AUROC (95% confidence interval) of the APACHE II score was 0.72 (0.65-0.80) for 30-day mortality, 0.70 (0.64-0.76) for 90-day mortality and 0.65 (0.59-0.71) for admission to the intensive care unit. The CCI performed better in prediction of 90-day mortality (P = .04). All other results for the ASA score and CCI were comparable with the APACHE II score.CONCLUSION: The APACHE II score predicted mortality moderately and admission to intensive care unit poorly in emergency abdominal surgical patients.

AB - BACKGROUND: Patients undergoing emergency abdominal surgery are at high risk of morbidity and mortality. Accurate identification of high-risk patients is important. The Acute Physiology and Chronic Health Evaluation (APACHE) II score needs to be validated in a larger heterogeneous population before implementation. We aimed to assess the predictive value of the APACHE II score in emergency abdominal surgical patients. Furthermore, we compared the APACHE II score with the American Society of Anesthesiologists (ASA) physical status score and the Charlson Comorbidity Index (CCI).METHODS: We included adult patients undergoing emergency abdominal surgery screened for enrolment in the InCare trial from October 2010 to November 2012. The APACHE II score was evaluated with area under the receiver operating characteristics curve (AUROC) statistics. The primary outcome was 30-day mortality. Secondary outcomes included 90-day mortality and admission to the intensive care unit.RESULTS: We included a total of 885 patients. All-cause 30-day mortality was 5.0%, 90-day mortality was 8.9%, and a total of 7.9% of the patients were admitted to the intensive care unit. The AUROC (95% confidence interval) of the APACHE II score was 0.72 (0.65-0.80) for 30-day mortality, 0.70 (0.64-0.76) for 90-day mortality and 0.65 (0.59-0.71) for admission to the intensive care unit. The CCI performed better in prediction of 90-day mortality (P = .04). All other results for the ASA score and CCI were comparable with the APACHE II score.CONCLUSION: The APACHE II score predicted mortality moderately and admission to intensive care unit poorly in emergency abdominal surgical patients.

U2 - 10.1111/aas.13476

DO - 10.1111/aas.13476

M3 - Journal article

C2 - 31529462

VL - 64

SP - 180

EP - 187

JO - Acta Anaesthesiologica Scandinavica

JF - Acta Anaesthesiologica Scandinavica

SN - 0001-5172

IS - 2

ER -

ID: 249630953